Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pancreatic Cancer for Phase II”

490 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 490 results

Testing effectiveness (Phase 2)UnknownNCT05371223
What this trial is testing

Combined Nabpaclitaxel Pressurized IntraPeritoneal Aerosol Chemotherapy With Systemic Nabpaclitaxel-Gemcitabine Chemotherapy for Pancreatic Cancer Peritoneal Metastases

Who this might be right for
Peritoneal CarcinomatosisPancreas Neoplasm
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 38
Testing effectiveness (Phase 2)Study completedNCT00602082
What this trial is testing

Capecitabine and Streptozocin With or Without Cisplatin in Treating Patients With Unresectable or Metastatic Neuroendocrine Tumors

Who this might be right for
Gastrointestinal Carcinoid TumorIslet Cell Tumor
Cambridge University Hospitals NHS Foundation Trust 84
Not applicableLooking for participantsNCT05334069
What this trial is testing

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaAnn Arbor Stage I Lymphoma+59 more
Alliance for Clinical Trials in Oncology 2,000
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07469956
What this trial is testing

Surufatinib Plus mFOLFIRINOX and PD-1 Inhibitor as the Neoadjuvant Therapy for High-risk or Borderline Resectable Pancreatic Cancer

Who this might be right for
Pancreatic Cancer Resectable
Sun Yat-sen University 30
Testing effectiveness (Phase 2)Study completedNCT04524702
What this trial is testing

Paricalcitol and Hydroxychloroquine in Combination With Gemcitabine and Nab-Paclitaxel for Advanced Pancreatic Cancer

Who this might be right for
Advanced Pancreatic AdenocarcinomaMetastatic Pancreatic AdenocarcinomaStage IV Pancreatic Cancer AJCC v8
Emory University 10
Testing effectiveness (Phase 2)UnknownNCT03403101
What this trial is testing

The Combination Chemotherapy of SIRIOX as First- or Second-Line Chemotherapy for Pancreatic Cancer

Who this might be right for
Carcinoma, Pancreatic Ductal
Fudan University 65
Testing effectiveness (Phase 2)Ended earlyNCT01921751
What this trial is testing

High or Standard Intensity Radiation Therapy After Gemcitabine Hydrochloride and Nab-paclitaxel in Treating Patients With Pancreatic Cancer That Cannot Be Removed by Surgery

Who this might be right for
Pancreatic AdenocarcinomaStage III Pancreatic Cancer
Radiation Therapy Oncology Group 20
Testing effectiveness (Phase 2)Looking for participantsNCT04503265
What this trial is testing

A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies

Who this might be right for
Advanced Malignant NeoplasmBreast CancerOvarian Cancer+3 more
AtlasMedx, Incorporated 122
Not applicableStudy completedNCT06947395
What this trial is testing

Clinical Validation of a Blood Biomarker Test to Detect Early-Stage Pancreatic Cancer (VERIFI)

Who this might be right for
Cancer of the PancreasPancreatic CancerPancreas Neoplasms+2 more
Immunovia, Inc. 386
Testing effectiveness (Phase 2)Study completedNCT03410030
What this trial is testing

Trial of Ascorbic Acid (AA) + Nanoparticle Paclitaxel Protein Bound + Cisplatin + Gemcitabine (AA NABPLAGEM)

Who this might be right for
Pancreatic CancerPancreas CancerPancreatic Adenocarcinoma Resectable+2 more
HonorHealth Research Institute 17
Testing effectiveness (Phase 2)Study completedNCT03225989
What this trial is testing

Trial Investigating an Immunostimulatory Oncolytic Adenovirus for Cancer

Who this might be right for
Pancreatic AdenocarcinomaOvarian CancerBiliary Carcinoma+1 more
Lokon Pharma AB 47
Not applicableStudy completedNCT03323489
What this trial is testing

Celiac Plexus Radio-Surgery for Pain Management

Who this might be right for
Advanced CancerPancreas CancerPain
Dr. Yaacov Lawrence 125
Testing effectiveness (Phase 2)Study completedNCT00161213
What this trial is testing

Gemcitabine and Imatinib Mesylate as First-Line Therapy in Patients With Locally Adv. or Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
University of Medicine and Dentistry of New Jersey 44
Testing effectiveness (Phase 2)WithdrawnNCT00253526
What this trial is testing

Gemcitabine Hydrochloride With or Without Bevacizumab in Treating Patients Who Are Undergoing Surgery for Pancreatic Cancer

Who this might be right for
Adenocarcinoma of the PancreasRecurrent Pancreatic CancerStage I Pancreatic Cancer+2 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT01222689
What this trial is testing

Selumetinib and Erlotinib Hydrochloride in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer

Who this might be right for
Adenocarcinoma of the PancreasRecurrent Pancreatic CancerStage III Pancreatic Cancer+1 more
National Cancer Institute (NCI) 46
Testing effectiveness (Phase 2)Ended earlyNCT00889187
What this trial is testing

Neoadjuvant Accelerated Short Course Radiation Therapy With Photons and Capecitabine for Resectable Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Dana-Farber Cancer Institute 10
Testing effectiveness (Phase 2)UnknownNCT01372735
What this trial is testing

Trial of Neoadjuvant Short Course IMRT Followed by Surgery and IORT for Resectable Pancreatic Cancer

Who this might be right for
Pancreatic Neoplasms
University Hospital Heidelberg 46
Testing effectiveness (Phase 2)Looking for participantsNCT06423326
What this trial is testing

Gemcitabine, Cisplatin and Nab-Paclitaxel as Neoadjuvant Treatment for Patients With Resectable or Borderline Resectable Pancreatic Cancer

Who this might be right for
Borderline Resectable Pancreatic Ductal AdenocarcinomaResectable Pancreatic AdenocarcinomaStage I Pancreatic Cancer AJCC v8+2 more
Emory University 36
Testing effectiveness (Phase 2)WithdrawnNCT02850874
What this trial is testing

HIPEC as Neoadjuvant Treatment for Resectable Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic NeoplasmsPancreatic Adenocarcinoma
Wake Forest University Health Sciences
Testing effectiveness (Phase 2)Study completedNCT02080221
What this trial is testing

BrUOG 292: FOLFOX-A For Metastatic Pancreatic Cancer: A Phase II Brown University Oncology Research Group Trial

Who this might be right for
Metastatic Pancreatic Cancer
Brown University 50
Next Page